Skip to main content

Journal Club - December 2, 2021


Dr. Nav Malhi presented the CTCR-MVS Trial, which is a randomized, surgical trial comparing mitral valve surgery with or without tricuspid annuloplasty (TA) among patients who were undergoing mitral-valve surgery for degenerative mitral regurgitation with either moderate tricuspid regurgitation or less-than-moderate regurgitation with annular dilatation of 40 mm or more. The primary end point at 2 years was a composite of reoperation for tricuspid regurgitation, progression of tricuspid regurgitation from baseline by two grades or the presence of severe tricuspid regurgitation, or death.

CCI is an inclusive centre with multidisciplinary membership for all cardiovascular investigators in BC